Absence of activated protein C resistance in nonmetastatic gastric cancer patients

Experimental Oncology

Volumn 25, Issue 3, 2003, Pages 231-232

  Di Micco, P ^a   Castaldo, G ^a   Granata, G ^a   Niglio, A ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Cancer acquired thrombophilia; Factor V Leiden; Gastric cancer; Hypercoagulable state

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5 LEIDEN; DNA; FIBRINOGEN; PROTHROMBIN;

ACTIVATED PROTEIN C RESISTANCE; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBRINOLYSIS; HUMAN; HYPERCOAGULABILITY; MALE; METASTASIS; PARTIAL THROMBOPLASTIN TIME; POLYMERASE CHAIN REACTION; PROTHROMBIN TIME; STOMACH CANCER; THROMBOPHILIA; VEIN THROMBOSIS; ADVANCED CANCER; CANCER PATIENT;

EID: 0142118373     PISSN: 02043564     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Di Micco P, De Lucia D, De Vita F, Niglio A, Di Micco G, Martinelli E, Chirico G, D'Uva M, Torella R. Acquired cancer-related thrombophilia testified by increased levels of prothrombin frament 1+2 and d-dimer in patients affected by solid tumors. Exp Oncol 2002; 24: 108-11.
2. Falanga A. Tumor cell prothrombotic properties. Haemostasis 2001; 31: 1-4.
3. nd ed. Bailliere JB, ed. Paris: J.B. Bailliere et fils, 1865; 3: 654-712.
4. Hathaway WE, Goodnight Scott Jr. Thrombosis and cancer. In: Disorder of haemostasis and thrombosis. Hathaway WE, Goodnight Scott Jr, eds. New York: Mc Graw Hill, 1991: 394-400.
5. Rickles FR, Levine MN. Epidemiology of thrombosis in cancer. Acta Haematol 2001; 106: 6-12.
6. Gouin-Thibault I, Achkar A, Samama MM. The thrombophilic state in cancer patients. Acta Haematol 2001; 106: 33-42.
7. Tiutrin II, Karpov AB, Udut VV, Tsisik RM, Solokhina EA. Disorder of haemostatic system in patients with disseminated stomach cancer. Vopr Onkol 1989; 35: 460-5 (In Russian).
8. De Lucia D, De Vita F, Orditura M, Renis V, Belli A, Conte M, di Grazia M, Iacoviello L, Donati MB, Catalano G. Hypercoagulable state in patients with advanced gastrointestinal cancer: evidence for an acquired resistance to activated protein C. Tumori 1997; 83: 948-52.
9. Di Micco P, Romano M, Niglio A, Nozzolillo P, Federico A, Petronella P, Nunziata L, Di Micco B, Torella R. Alteration of haemostasis in nonmetastatic gastric cancer. Dig Liver Dis 2001; 33: 546-50.
10. Dahlback B. The discovery of activated protein C resistance. J Thromb Haemost 2003; 1: 3-9.
11. Martinelli I. Risk factors in venous thromboembolism. Thromb Haemost 2001; 86: 395-403.
12. Di Micco P, Niglio A, Chirico G, Russo F, Izzo T, Castaldo G, D'Uva M, Moraca L, De Vita F, Diadema MR. Significant reduction of free S protein in women receiving chemoendocrine adjuvant therapy for breast cancer based on intravenous CMF administration and oral tamoxifen. Exp Oncol 2002; 24: 301-4.